The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has launched a new clinical trials network. Called the COVID-19 Prevention Trials Network (CoVPN), it merges four clinical trial networks across the country.
“We are looking to recruit millions of people into this registry by September,” says Jim Kublin, MD, executive director of the operations program of CoVPN, coordinated by the Fred Hutchinson Cancer Research Center in Seattle.
For more information about the network, go HERE. To read the entire article, go HERE.
If black people, and women of all colors don’t participate in the trials, we won’t know if a vaccine works the same way as it does on white males, who are the usual test groups.
Wild Cooking Woman
Total Page Visits: 664 - Today Page Visits: 1